Financial Daily from THE HINDU group of publications
Sunday, Apr 11, 2004

Investment World
Features
Stocks
Port Info
Archives

Group Sites

Investment World - Mutual Funds
Markets - Mutual Funds


Reliance Vision Fund: Invest in phased manner

S. Vaidya Nathan

INVESTORS with a penchant for high risk can contemplate exposures in Reliance Vision Fund. It has a good track record, especially over the past three years.

The fund is aggressively managed and has taken advantage of market trends by a high degree of profit booking and portfolio churn. Investments can be made in a phased manner to benefit from any price weakness in the broad market.

Reliance Vision has been among the top performers in the bull market of 2003. Recording returns of about 140 per cent, the fund has done well post its focus on several large-cap stocks. Its performance has been consistent across quarters over the past three years.

The annual return since its launch in 1995 is about 25 per cent with a sizeable proportion sourced from the performance of the past year.

Suitability: Reliance Vision has a diversified portfolio without any concentrated sector exposures. The sector exposure has been capped at 10 per cent with only a few accounting for more than 5 per cent of assets. Much the same holds true for stocks with the top five holdings accounting for 25 per cent of net assets.

What enhances the risk profile is the aggressive nature of fund management. The fund has delivered returns that more than compensate for the risk element involved. Investors can choose the dividend option as the benefit of tax exemption may be extended when the Budget is presented in a few months. The dividend option will also enable investors to take cash out to capitalise on NAV gains.

Portfolio overview: The portfolio has a mix of large-cap and mid-cap stocks with the former dominating the top holdings. Pharmaceutical, steel, engineering, auto and chemicals form the top sector exposures. The prominent mid-cap stocks are Ashok Leyland, Sesa Goa, Television 18, Divi's Labs, Bharat Forge and Great Eastern Shipping.

The fund has focussed on mid-cap export plays in the pharma sector such as Lupin and Aurobindo apart from Divi's. The portfolio appears well placed to benefit from the broad-based growth in the economy as well as the firm trends in commodity prices.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
On stock option and employee stock ownership plans


Foreign shareholdings in India Inc — Tugging at market strings
Long-term debt investing — A case for lowering costs
The ONGC share allotment fiasco
Crisil: A compact but powerful research house
Reliance Vision Fund: Invest in phased manner
Franklin India Prima Plus: Invest in phases
UTI Pharma and Healthcare Fund
Fund talk
Pidilite Industries: Hold
Colgate-Palmolive India: Pare exposures
Vardhman Spinning: Buy
Zee Telefilms: Book profits partially
Crisil: Hold/Buy on declines
MphasiS BFL: Banking on BPO
Query Corner
Indices in indecisive zone
Reliance in consolidation mode
Focus of the week
TVS Centra: Mileage from technology
Question `n' Auto
SBI Life's Housing Loan Cover Plan
Sweet run for sugar stocks
Uptrend in ICICI Bank
Nifty may tread on negative terrain
Using futures/options
Options guide
Futures guide
ICICI Bank's Visa Mini Card
Sundaram Home Finance: For a short stay
`Crisil has been able to differentiate itself'
Second house on wife's land
Remedy for a double loss
Datamatics Technologies: Invest
You don't have to win every lap to win the race


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line